The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.
The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.
Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.
This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.
Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million.
Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.